IBD (Inflammatory Bowel Disease)
IBD (Inflammatory Bowel Disease) is a condition associated with digestive health and inflammation in the bowel. It is distinct from a general description of digestive discomfort, although no specific symptoms are defined here.
IBD (Inflammatory Bowel Disease) is a condition associated with digestive health.
This list shows research findings, not treatments. Nothing here replaces medical care. If you have this condition, talk to a doctor.
What may help
What studies found for each option, best evidence first.
7 options:1 some evidence6 not enough evidence
Acceptance and Commitment Therapy (ACT)practiceSome evidence it helpsSize of effect: Not known
Some human studies found a benefit. More research could change this.
All 2 studies with a clear result found a benefit.
A pooled analysis of nine randomized and non-randomized human studies in people with IBD reported reduced anxiety, depression and stress versus comparators, with the anxiety effect statistically significant. In an RCT of 120 people, ACT improved health-related quality of life and Crohn's disease activity versus an active control.
Open the Acceptance and Commitment Therapy (ACT) pageYogapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A pooled analysis of 7 randomized trials in people with IBD reported psychological benefit from Yoga-based mind-body interventions, specifically reduced anxiety.
Open the Yoga pageAnusara YogapracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
Pooled randomized trials of Yoga-based mind-body interventions in people with IBD reported anxiety and psychological outcomes.
Open the Anusara Yoga pageMeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2024 pooled analysis whose study designs were not recorded reported reduced anxiety and depression and improved quality of life with mindfulness-based interventions in people with inflammatory bowel disease.
Open the Meditation pageBrisk WalkingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A 2025 randomized controlled trial in 49 obese people with IBD found reductions in BMI and body fat percentage after a 10-week walking program.
Open the Brisk Walking pageMindfulness MeditationpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A single-arm feasibility trial found improvements in anxiety, depression, and quality of life that persisted at 6-month follow-up; 7 people completed the trial.
Open the Mindfulness Meditation pageSwimmingpracticeNot enough evidence
Too few or too small studies to know if it works.
The one study found a benefit.
A review of 3 rodent studies reported that swimming consistently improved macroscopic and microscopic colitis outcomes; this does not establish an effect in people with IBD.
Open the Swimming page
The expert view shows every study, dose protocol and source.
What may help
Interventions recorded as helping with this condition7 listedMost likely to help, from the evidence we have
- →PracticesAcceptance and Commitment Therapy (ACT)CertaintyMediumSourceRCT
A pooled analysis of nine randomized and non-randomized human studies in people with IBD reported reduced anxiety, depression and stress versus comparators, with the anxiety effect statistically significant. In an RCT of 120 people, ACT improved health-related quality of life and Crohn's disease activity versus an active control.
Who was studied
- People with a condition
- Ulcerative Colitis
Open Acceptance and Commitment Therapy (ACT)Study result
Pooled analysis of nine studies reported reduced anxiety, depression and stress versus comparators in IBD patients; anxiety effect statistically significant.
Low probability(6)
- →PracticesYogaCertaintyLowSourceMeta-analysis
A pooled analysis of 7 randomized trials in people with IBD reported psychological benefit from Yoga-based mind-body interventions, specifically reduced anxiety.
Who was studied
- People with a condition
- Ibd
Open YogaStudy result
Meta-analysis of seven RCTs in patients with IBD reporting psychological benefit (anxiety reduction) from yoga-based mind-body interventions.
- →PracticesAnusara YogaCertaintyLowSourceRCT
Pooled randomized trials of Yoga-based mind-body interventions in people with IBD reported anxiety and psychological outcomes.
Who was studied
- People with a condition
- Ibd
Open Anusara YogaStudy result
Pooled RCTs of yoga-based mind-body interventions in IBD patients; reported anxiety and psychological outcomes.
- →PracticesMeditationCertaintyLowSourceRCT
A 2024 pooled analysis whose study designs were not recorded reported reduced anxiety and depression and improved quality of life with mindfulness-based interventions in people with inflammatory bowel disease.
Who was studied
- People with a condition
Open MeditationStudy result
Meta-analysis of 14 RCTs showing significant reduction in anxiety and depression and improvement in quality of life with mindfulness-based interventions.
- →PracticesBrisk WalkingCertaintyLowSourceClinical
A 2025 randomized controlled trial in 49 obese people with IBD found reductions in BMI and body fat percentage after a 10-week walking program.
Who was studied
- People with a condition
- Ibd
- Obesity
Open Brisk WalkingStudy result
RCT showing significant reductions in BMI and body fat percentage in obese IBD patients after 10-week walking program.
- →PracticesMindfulness MeditationCertaintyLowSourceClinical
A single-arm feasibility trial found improvements in anxiety, depression, and quality of life that persisted at 6-month follow-up; 7 people completed the trial.
Who was studied
- People with a condition
Open Mindfulness MeditationStudy result
Single-arm feasibility trial (n=7 completers) showing improvements in anxiety, depression, and QoL that persisted at 6-month follow-up
- →PracticesSwimmingCertaintyLowSourceClinical
A review of 3 rodent studies reported that swimming consistently improved macroscopic and microscopic colitis outcomes; this does not establish an effect in people with IBD.
Open SwimmingStudy result
Systematic review of 3 rodent studies showing swimming consistently improved macroscopic and microscopic colitis outcomes.
What to avoid
Interventions recorded as making it worseNothing in this library is currently recorded as making IBD (Inflammatory Bowel Disease) worse. Coverage is partial, and absence here is not evidence of safety.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
IBD (Inflammatory Bowel Disease) is a condition associated with digestive health and inflammation in the bowel. It is distinct from a general description of digestive discomfort, although no specific symptoms are defined here.
The options shown for IBD include findings from animal studies and a review. These findings do not by themselves establish that the observed effects apply to people with IBD, so the interventions should be understood as areas of study rather than interchangeable treatments.
Evidence-backed options
The evidence for these options in IBD is preliminary. Most findings come from animal studies or reviews, and the listed likelihood of benefit is low. The animal research used models of colitis in rats and mice, so it does not establish whether the same effects occur in people with Crohn’s disease or ulcerative colitis.
The findings point to several overlapping areas of interest, including intestinal inflammation, gut-microbiota composition, epithelial or intestinal barrier integrity, and oxidative stress. Berberine was studied in rats at 40 mg/kg for 7 days and at 100 mg/kg orally in another experiment; the specific timing of effects was not established beyond that 7-day period. Other animal findings involved changes in inflammatory cytokines, colon inflammation, weight loss, colon shortening, epithelial injury, and barrier integrity.
For most options, a human dose, treatment duration, and time to onset are not specified. Vitamin E is the exception in that the cited investigations involved patients with Crohn’s disease or ulcerative colitis, but the available summary does not provide enough detail to determine the dose, duration, or how quickly changes appeared. Reviews of Curcumin, Quercetin, Saccharomyces Boulardii, Saffron Extract, and Vitamin E describe potentially beneficial findings, while the overall evidence remains limited. These options should therefore be interpreted as areas of investigation rather than established replacements for clinical care.
What to avoid
Dietary Fiber (Prebiotics) is flagged because high fiber intake may be poorly tolerated during active IBD flares, including Crohn's disease and ulcerative colitis. In this setting, it can worsen abdominal pain and diarrhea and may increase the risk of bowel obstruction. The concern is specific to periods of acute inflammation rather than necessarily applying in the same way during remission, when fiber may be reintroduced gradually. Fiber intake should be considered in the context of current symptoms and disease activity, with a clinician helping determine an appropriate approach for an individual medical condition.